RNA binding proteins (RBPs) on genetic stability and diseases

Abdullahi Tunde Aborode , Ohilebo Abdulateef Abass , Shaibu Nasiru , Mary Ugunnushe Eigbobo , Sumana Nefishatu , Abdullahi Idowu , Zainab Tiamiyu , Aeshah A. Awaji , Nike Idowu , Babawale Roqeeb Busayo , Qasim Mehmood , Isreal Ayobami Onifade , Sodiq Fakorede , Ashraf Akintayo Akintola

Global Medical Genetics ›› 2025, Vol. 12 ›› Issue (01) : 100032

PDF (3297KB)
Global Medical Genetics ›› 2025, Vol. 12 ›› Issue (01) :100032 DOI: 10.1016/j.gmg.2024.100032
Review article
research-article
RNA binding proteins (RBPs) on genetic stability and diseases
Author information +
History +
PDF (3297KB)

Abstract

RNA-binding proteins (RBPs) are integral components of cellular machinery, playing crucial roles in the regulation of gene expression and maintaining genetic stability. Their interactions with RNA molecules govern critical processes such as mRNA splicing, stability, localization, and translation, which are essential for proper cellular function. These proteins interact with RNA molecules and other proteins to form ribonucleoprotein complexes (RNPs), hence controlling the fate of target RNAs. The interaction occurs via RNA recognition motif, the zinc finger domain, the KH domain and the double stranded RNA binding motif (all known as RNA-binding domains (RBDs). These domains are found within the coding sequences (intron and exon domains), 5’ untranslated regions (5’UTR) and 3’ untranslated regions (3’UTR). Dysregulation of RBPs can lead to genomic instability, contributing to various pathologies, including cancer neurodegenerative diseases, and metabolic disorders. This study comprehensively explores the multifaceted roles of RBPs in genetic stability, highlighting their involvement in maintaining genomic integrity through modulation of RNA processing and their implications in cellular signalling pathways. Furthermore, it discusses how aberrant RBP function can precipitate genetic instability and disease progression, emphasizing the therapeutic potential of targeting RBPs in restoring cellular homeostasis. Through an analysis of current literature, this study aims to delineate the critical role of RBPs in ensuring genetic stability and their promise as targets for innovative therapeutic strategies.

Keywords

RNA binding proteins / Genetic stability / Diseases

Cite this article

Download citation ▾
Abdullahi Tunde Aborode, Ohilebo Abdulateef Abass, Shaibu Nasiru, Mary Ugunnushe Eigbobo, Sumana Nefishatu, Abdullahi Idowu, Zainab Tiamiyu, Aeshah A. Awaji, Nike Idowu, Babawale Roqeeb Busayo, Qasim Mehmood, Isreal Ayobami Onifade, Sodiq Fakorede, Ashraf Akintayo Akintola. RNA binding proteins (RBPs) on genetic stability and diseases. Global Medical Genetics, 2025, 12(01): 100032 DOI:10.1016/j.gmg.2024.100032

登录浏览全文

4963

注册一个新账户 忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within
[1]

A. Corbett, Post-transcriptional regulation of gene expression and human disease, Curr. Opin. Cell Biol. 52 (2018) 96-104, https://doi.org/10.1016/j.ceb.2018.02.011.
[2]

E. Dassi, Handshakes and fights: the regulatory interplay of RNA-binding proteins, Front Mol. Biosci. 4 (2017) 67.
[3]

M.E. Leonart, Understanding RNA-binding proteins, Semin. Cancer Biol. 86 (Pt 3) (2022) 135-136, https://doi.org/10.1016/j.semcancer.2022.06.015.
[4]

Adamek M. (2023). Molecular grammar of rna-binding protein interactions in formation and function of ribonucleoprotein complexes. 〈 https://doi.org/10.55295/psl.2023.ii15〉.
[5]

M. Corley, M.C. Burns, G.W. Yeo, How RNA-binding proteins interact with RNA: molecules and mechanisms, Mol. Cell 78 (1) (2020) 9-29, https://doi.org/10.1016/j.molcel.2020.03.011 PMID: 32243832; PMCID: PMC7202378.
[6]

M. Corley, M.C. Burns, G.W. Yeo, How RNA-binding proteins interact with RNA: molecules and mechanisms, Mol. Cell 78 (1) (2020) 9-29, https://doi.org/10.1016/j.molcel.2020.03.011.
[7]

Y. Li, W. Zhou, Q. Jie, T. Pan, J. Shi, T. Jiang, Y. Ma, Single-Cell Rna Bind. Protein Regul. Netw. Anal. Reveal Oncog. hnrnpk-myc Signal. Pathw. Cancer (2022), https://doi.org/10.21203/rs.3.rs-1919283/v1.
[8]

M. Hentze, A. Castelló, T. Schwarzl, T. Preiß, A brave new world of rna-binding proteins, Nat. Rev. Mol. Cell Biol. 19 (5) (2018) 327-341, https://doi.org/10.1038/nrm.2017.130.
[9]

Q. Li, C. Kang, Targeting rna‐binding proteins with small molecules: perspectives, pitfalls and bifunctional molecules, Febs Lett. 597 (16) (2023) 2031-2047, https://doi.org/10.1002/1873-3468.14710.
[10]

S. Kelaini, C. Chan, V.A. Cornelius, A. Margariti, RNA-binding proteins hold key roles in function, dysfunction, and disease, Biology 10 (2021) 366.
[11]

A. Smirnov, Research progress in RNA-binding proteins, Int. J. Mol. Sci. 24 (1) (2022) 58, https://doi.org/10.3390/ijms24010058.
[12]

S. Agrawal, P.H. Kuo, L.Y. Chu, et al., RNA recognition motifs of disease-linked RNA-binding proteins contribute to amyloid formation, Sci. Rep. 9 (2019) 6171, https://doi.org/10.1038/s41598-019-42367-8.
[13]

M. Ramaswami, J. Taylor, R. Parker, Altered ribostasis: RNA-protein granules in degenerative disorders, Cell 154 (4) (2013) 727-736, https://doi.org/10.1016/j.cell.2013.07.038.
[14]

E. Wang, A. Ward, J. Cherone, J. Giudice, T. Wang, D. Treacy, C. Burge, Antagonistic regulation of mrna expression and splicing by celf and mbnl proteins, Genome Res. 25 (6) (2015) 858-871, https://doi.org/10.1101/gr.184390.114.
[15]

H. Zhou, M. Mangelsdorf, J. Liu, L. Zhu, J. Wu, RNA-binding proteins in neurological diseases, Sci. China Life Sci. 57 (4) (2014) 432-444, https://doi.org/10.1007/s11427-014-4647-9.
[16]

P. Lee, J. Chiang, C. Chen, Y. Chien, W. Chen, C. Huang, H. Lee, Calreticulin regulates vascular endothelial growth factor-a mrna stability in gastric cancer cells, Plos One 14 (11) (2019) e0225107, https://doi.org/10.1371/journal.pone.0225107.
[17]

T.N. Shukla, J. Song, Z.T. Campbell, Molecular entrapment by RNA: an emerging tool for disrupting protein-RNA interactions in vivo, RNA Biol. 17 (4) (2020) 417-424, https://doi.org/10.1080/15476286.2020.1717059Epub 2020 Jan 28. PMID: 31957541; PMCID: PMC7237136.
[18]

Y. Tao, Q. Zhang, H. Wang, et al., Alternative splicing and related RNA binding proteins in human health and disease, Sig Transduct. Target Ther. 9 (2024) 26, https://doi.org/10.1038/s41392-024-01734-2.
[19]

D. Ray, K. Ha, K. Nie, H. Zheng, T. Hughes, Q. Morris, Rnacompete methodology and application to determine sequence preferences of unconventional rna- binding proteins, Methods 118-119 (2017) 3-15, https://doi.org/10.1016/j.ymeth.2016.12.003.
[20]

H. Qin, H. Ni, Y. Liu, Y. Yang, T. Xi, X. Li, L. Zheng, Rna-binding proteins in tumor progression, J. Hematol. Oncol. 13 (1) (2020), https://doi.org/10.1186/s13045-020-00927-w.
[21]

W. Wang, R. Zhang, N. Feng, L. Zhang, N. Liu, Overexpression of rbm34 promotes tumor progression and correlates with poor prognosis of hepatocellular carcinoma, J. Clin. Transl. Hepatol. 000 (000) (2022), https://doi.org/10.14218/jcth.2022.00166.
[22]

Dardel F. (2016). Structure of an RNA recognition motif (RRM), showing the fold with the typical with beta-alpha-beta-beta-alpha-beta architecture. Available at: 〈 https://en.wikipedia.org/wiki/RNA_recognition_motif#/media/File:RRM.png〉.
[23]

S. Thomas, Cartoon Represent. zinc-Finger motif Proteins (2007) (Available at: 〈 https://en.wikipedia.org/wiki/Zinc_finger#/media/ File:Zinc_finger_rendered.png〉).
[24]

P.H. Backe, A.C. Messias, R.B. Ravelli, M. Sattler, S. Cusack, X-ray crystallographic and NMR studies of the third KH domain of hnRNP K in complex with single- stranded nucleic acids, Structure 13 (7) (2005) 1055-1067.
[25]

C. Petibon, M. Malik Ghulam, M. Catala, S. Abou Elela, Regulation of ribosomal protein genes: an ordered anarchy, Wiley Interdiscip. Rev.: RNA 12 (3) (2021) e1632.
[26]

C. Maris, C. Dominguez, F.H. Allain, The RNA recognition motif, a plastic RNA-binding platform to regulate posttranscriptional gene expression, FEBS J. 272 (2005) 2118-2131.
[27]

J.C. Venter, M.D. Adams, E.W. Myers, et al., The sequence of the human genome, Science 291 (2001) 1304-1351.
[28]

A. Clery, M. Blatter, F.H. Allain, RNA recognition motifs: boring? Not quite, Curr. Opin. Struc Biol. 18 (2008) 290-298.
[29]

F. Chen, Q. Wang, Y. Zhou, The construction and validation of an rna binding protein-related prognostic model for bladder cancer, BMC Cancer 21 (1) (2021), https://doi.org/10.1186/s12885-021-07930-5.
[30]

X. Chen, Z. Yang, W. Wang, K. Qian, M. Liu, J. Wang, M. Wang,Structural basis for RNA recognition by the N-terminal tandem RRM domains of human RBM45, Nucleic Acids Res. 49 (5) (2021) 2946-2958.
[31]

Y.S. Tsai, S.M. Gomez, Z. Wang, Prevalent RNA recognition motif duplication in the human genome, RNA 20 (5) (2014) 702-712, https://doi.org/10.1261/rna.044081.113 Epub 2014 Mar 25. PMID: 24667216; PMCID: PMC3988571.
[32]

S.A. Wolfe, L. Nekludova, C.O. Pabo, DNA recognition by Cys2His2 zinc finger proteins, Annu Rev. Bioph Biom. 29 (2000) 183-212.
[33]

M.K. Darby, RNA Binding by Single Zinc Fingers, in: N. Kuldell (Eds.),Zinc Finger Proteins. Molecular Biology Intelligence Unit, Springer, Boston, MA, 2005, https://doi.org/10.1007/0-387-27421-9_11.
[34]

T.M. Hall, Multiple modes of RNA recognition by zinc finger proteins, Curr. Opin. Struct. Biol. 15 (3) (2005) 367-373, https://doi.org/10.1016/j.sbi.2005.04.004 PMID: 15963892.
[35]

R.S. Brown, Zinc finger proteins: getting a grip on RNA, Curr. Opin. Struct. Biol. 15 (1) (2005) 94-98.
[36]

N.V. Grishin, KH domain: one motif, two folds, Nucleic Acids Res 29 (2001) 638-643.
[37]

R. Valverde, L. Edwards, L. Regan, Structure and function of KH domains, FEBS J. 275 (2008) 2712-2726.
[38]

B. Beuth, S. Pennell, K.B. Arnvig, et al., Structure of a mycobacterium tuberculosis NusA-RNA complex, EMBO J. 24 (2005) 3576-3587.
[39]

M.Z. Jia, S. Horita, K. Nagata, et al., An archaeal Dim2-like protein, aDim2p, forms a ternary complex with a/eIF 2 alpha and the 3′ end fragment of 16S rRNA. J. Mol. Biol. 398 (2010) 774-785.
[40]

R. Stefl, L. Skrisovska, F.H. Allain, RNA sequence- and shape-dependent recognition by proteins in the ribonucleoprotein particle, EMBO Rep. 6 (2005) 33-38.
[41]

K.Y. Chang, A. Ramos, The double-stranded RNA-binding motif, a versatile macromolecular docking platform, FEBS J. 272 (2005) 2109-2117.
[42]

G. Masliah, P. Barraud, F.H. Allain, RNA recognition by double-stranded RNA binding domains: a matter of shape and sequence, Cell Mol. Life Sci. 70 (11) (2013) 1875-1895, https://doi.org/10.1007/s00018-012-1119-x.
[43]

W. Xinlei, V. Lela, R.K. Hye, S. Klaus, M. Sua, Dynamic profiling of double-stranded RNA binding proteins, Nucleic Acids Res. 43 (15) (2015) 7566-7576.
[44]

L. Yuan, D. Protter, M. Rosen, R. Parker, Formation and maturation of phase-separated liquid droplets by rna-binding proteins, Mol. Cell 60 (2) (2015) 208-219, https://doi.org/10.1016/j.molcel.2015.08.018.
[45]

S. Sohrabi-Jahromi, J. Söding, Thermodynamic modeling reveals widespread multivalent binding by rna-binding proteins, Bioinformatics 37 (ement_1) (2021) i308-i316, https://doi.org/10.1093/bioinformatics/btab300.
[46]

D.S.M. Ottoz, L.E. Berchowitz, The role of disorder in RNA binding affinity and specificity, Open Biol. 10 (12) (2020) 200328,https://doi.org/10.1098/rsob.200328 Epub 2020 Dec 23. PMID: 33352065; PMCID: PMC7776568.
[47]

A. Zeke, É. Schád, T. Horváth, R. Abukhairan, B. Szabó, A. Tantos, Deep structural insights into RNA-binding disordered protein regions, Wiley Inter. Rev. RNA 13 (5) (2022) e1714,https://doi.org/10.1002/wrna.1714 Epub 2022 Jan 30. PMID: 35098694; PMCID: PMC9539567.
[48]

P. Malaney, O. Benitez, X. Zhang, S.M. Post, Assessing the role of intrinsic disorder in RNA-binding protein function: hnRNP K as a case study, Methods 208 (2022) 59-65.
[49]

C. Qiu, Z. Zhang, R.N. Wine, et al., Intra- and inter-molecular regulation by intrinsically-disordered regions governs PUF protein RNA binding, Nat. Commun. 14 (2023) 7323, https://doi.org/10.1038/s41467-023-43098-1.
[50]

W. Xi, S.B. Lavi, M.G. Harry, Y. Binhan, L. Yaakov, I. Junji, Negatively charged, intrinsically disordered regions can accelerate target search by DNA-binding proteins, Nucleic Acids Res. 51 (10) (2023) 4701-4712.
[51]

D. Domínguez, P. Freese, M. Alexis, A. Su, M. Hochman, T. Palden, C. Burge, Sequence, structure, and context preferences of human rna binding proteins, Mol. Cell 70 (5) (2018) 854-867.e9, https://doi.org/10.1016/j.molcel.2018.05.001.
[52]

J. Taliaferro, N. Lambert, P. Sudmant, D. Domínguez, J. Merkin, M. Alexis, C. Burge, Rna sequence context effects measured in vitro predict in vivo protein binding and regulation, Mol. Cell 64 (2) (2016) 294-306, https://doi.org/10.1016/j.molcel.2016.08.035.
[53]

A. Jolma, J. Zhang, E. Mondragón, E. Morgunova, T. Kivioja, K. Laverty, J. Taipale, Binding specificities of human rna-binding proteins toward structured and linear rna sequences, Genome Res. 30 (7) (2020) 962-973, https://doi.org/10.1101/gr.258848.119.
[54]

T. Glisovic, J.L. Bachorik, J. Yong, G. Dreyfuss, "RNA-binding proteins and post transcriptional gene regulation", FEBS Lett. 582 (14) (2008) 1977-1986, https://doi.org/10.1016/j.febslet.2008.03.004.
[55]

T. Glisovic, J. Bachorik, J. Yong, G. Dreyfuss, Rna‐binding proteins and post‐transcriptional gene regulation, Febs Lett. 582 (14) (2008) 1977-1986, https://doi.org/10.1016/j.febslet.2008.03.004.
[56]

M. Wang, L. Ogé, M. Pérez-Garcia, L. Hamama, S. Sakr, The puf protein family: overview on puf rna targets, biological functions, and post transcriptional regulation, Int. J. Mol. Sci. 19 (2) (2018) 410, https://doi.org/10.3390/ijms19020410.
[57]

C. Marondedze, L. Thomas, N. Serrano, K. Lilley, C. Gehring, The rna-binding protein repertoire of Arabidopsis thaliana, Sci. Rep. 6 (1) (2016), https://doi.org/10.1038/srep29766.
[58]

P. Tam, I. Barrette-Ng, D. Simon, M. Tam, A. Ang, D. Muench, The puf family of rna-binding proteins in plants: phylogeny, structural modeling, activity and subcellular localization, BMC Plant Biol. 10 (1) (2010), https://doi.org/10.1186/1471-2229-10-44.
[59]

T. Brazão, J. Demmers, W. IJcken, J. Strouboulis, M. Fornerod, L. Romão, F. Grosveld, A new function of rod1 in nonsense‐mediated mrna decay, Febs Lett. 586 (8) (2012) 1101-1110, https://doi.org/10.1016/j.febslet.2012.03.015.
[60]

X. Liang, W. Chen, H. Shi, X. Gu, Y. Li, Y. Qi, J. Liu, Ptbp 3 contributes to the metastasis of gastric cancer by mediating cav1 alternative splicing, Cell Death Dis. 9 (5) (2018), https://doi.org/10.1038/s41419-018-0608-8.
[61]

S. Cao, L. Xiao, J. Wang, G. Chen, Y. Liu, The rna-binding protein hur regulates intestinal epithelial restitution by modulating caveolin-1 gene expression, Biochem. J. 478 (1) (2021) 247-260, https://doi.org/10.1042/bcj20200372.
[62]

J. Li, S. Deng, J. Vieira, J. Thomas, V. Costa, C. Tseng, P. Yu, Rbpmetadb: a comprehensive annotation of mouse rna-seq datasets with perturbations of rna- binding proteins (2018), https://doi.org/10.1101/326116.
[63]

A. Quattrone, E. Dassi, The architecture of the human RNA-binding protein regulatory network, iScience 21 (2019) 706-719.
[64]

M. Mirza-Aghazadeh-Attari, S.G. Darband, M. Kaviani, A. Mihanfar, J. Aghazadeh Attari, B. Yousefi, M. Majidinia, DNA damage response and repair in colorectal cancer: defects, regulation and therapeutic implications, DNA Repair 69 (2018) 34-52, https://doi.org/10.1016/j.dnarep.2018.07.005.
[65]

S. Keeney, J. Lange, N. Mohibullah, Self-organization of meiotic recombination initiation: general principles and molecular pathways, Annu. Rev. Genet. 48 (1) (2014) 187-214, https://doi.org/10.1146/annurev-genet-120213-092304.
[66]

J. Li, H. Sun, Y. Huang, Y. Wang, Y. Liu, X. Chen, Pathways and assays for DNA double-strand break repair by homologous recombination, Acta Biochim. Et. Biophys. Sin. 51 (9) (2019) 879-889, https://doi.org/10.1093/abbs/gmz076.
[67]

V.E. Provasek, J. Mitra, V.H. Malojirao, M.L. Hegde, DNA double-strand breaks as pathogenic lesions in neurological disorders, Int. J. Mol. Sci. 23 (9) (2022) 4653, https://doi.org/10.3390/ijms23094653.
[68]

Y.-L. Wang, W.-W. Zhao, J. Shi, X.-B. Wan, J. Zheng, X.-J. Fan, Liquid-liquid phase separation in DNA double-strand breaks repair, Cell Death Dis. 14 (11) (2023) 746, https://doi.org/10.1038/s41419-023-06267-0.
[69]

G. Gurunathan, Z. Yu, Y. Coulombe, J. Masson, S. Richard, Arginine methylation of hnrnpul1 regulates interaction with nbs1 and recruitment to sites of dna damage, Sci. Rep. 5 (1) (2015), https://doi.org/10.1038/srep10475.
[70]

H. Zhang, J. Jiang, J. Ma, S. Dai, T. Xu, H. Li, A. Yasui, The role of hnrpul1 involved in dna damage response is related to parp1, Plos One 8 (4) (2013) e60208, https://doi.org/10.1371/journal.pone.0060208.
[71]

A. Mastrocola, S. Kim, A. Trinh, L. Rodenkirch, R. Tibbetts, The rna-binding protein fused in sarcoma (fus) functions downstream of poly(adp-ribose) poly-merase (parp) in response to dna damage, J. Biol. Chem. 288 (34) (2013) 24731-24741, https://doi.org/10.1074/jbc.m113.497974.
[72]

M. Sukhanova, A. Singatulina, D. Pastré, O. Lavrik, Fused in sarcoma (fus) in dna repair: tango with poly(adp-ribose) polymerase 1 and compartmentalisation of damaged dna, Int. J. Mol. Sci. 21 (19) (2020) 7020, https://doi.org/10.3390/ijms21197020.
[73]

A. Singatulina, L. Hamon, M. Sukhanova, B. Desforges, V. Joshi, A. Bouhss, D. Pastré, Parp-1 activation directs fus to dna damage sites to form parg-reversible compartments enriched in damaged dna, Cell Rep. 27 (6) (2019) 1809-1821.e5, https://doi.org/10.1016/j.celrep.2019.04.031.
[74]

T. Geuens, D. Bouhy, V. Timmerman, The hnRNP family: Insights into their role in health and disease, Hum. Genet. 135 (8) (2016) 851-867, https://doi.org/10.1007/s00439-016-1683-5.
[75]

S.J. Park, H. Lee, D.S. Jo, Y.K. Jo, J.H. Shin, H.B. Kim, H.M. Seo, D.C. Rubinsztein, J.-Y. Koh, E.K. Lee, D.-H. Cho, Heterogeneous nuclear ribonucleoprotein A1 post-transcriptionally regulates Drp1 expression in neuroblastoma cells, Biochim. Et. Biophys. Acta (BBA) - Gene Regul. Mech. 1849 (12) (2015) 1423-1431, https://doi.org/10.1016/j.bbagrm.2015.10.017.
[76]

M. Kai, Roles of RNA-binding proteins in DNA damage response, Int. J. Mol. Sci. 17 (3) (2016) 310, https://doi.org/10.3390/ijms17030310.
[77]

B. Mikolaskova, M. Jurcik, I. Cipakova, M. Kretova, M. Chovanec, L. Cipak, Maintenance of genome stability: the unifying role of interconnections between the DNA damage response and RNA-processing pathways, Curr. Genet. 64 (5) (2018) 971-983, https://doi.org/10.1007/s00294-018-0819-7.
[78]

B. Adamson, A. Smogorzewska, F. Sigoillot, R. King, S. Elledge, A genome-wide homologous recombination screen identifies the rna-binding protein rbmx as a component of the dna-damage response, Nat. Cell Biol. 14 (3) (2012) 318-328, https://doi.org/10.1038/ncb2426.
[79]

M. Marchesini, Y. Ogoti, E. Fiorini, A. Samur, L. Nezi, M. D’Anca, S. Colla, Ilf 2 is a regulator of rna splicing and dna damage response in 1q21-amplified multiple myeloma, Cancer Cell 32 (1) (2017) 88-100.e6, https://doi.org/10.1016/j.ccell.2017.05.011.
[80]

J. Krietsch, M. Caron, J. Gagné, C. Éthier, J. Vignard, M. Vincent, J. Masson, Parp activation regulates the rna-binding protein nono in the dna damage response to dna double-strand breaks, Nucleic Acids Res. 40 (20) (2012) 10287-10301, https://doi.org/10.1093/nar/gks798.
[81]

M. Yuan, C. Eberhart, M. Kai, Rna binding protein rbm14 promotes radio-resistance in glioblastoma by regulating dna repair and cell differentiation, Oncotarget 5 (9) (2014) 2820-2826, https://doi.org/10.18632/oncotarget.1924.
[82]

C. Rajesh, D. Baker, A. Pierce, D. Pittman, The splicing-factor related protein sfpq/psf interacts with rad51d and is necessary for homology-directed repair and sister chromatid cohesion, Nucleic Acids Res. 39 (1) (2010) 132-145, https://doi.org/10.1093/nar/gkq738.
[83]

Y. Zhao, X. Ye, M. Shehata, W. Dunker, Z. Xie, J. Karijolich, The RNA quality control pathway nonsense-mediated mRNA decay targets cellular and viral RNAs to restrict KSHV, Nat. Commun. 11 (1) (2020), https://doi.org/10.1038/s41467-020-17151-2.
[84]

J. Miller, D. Pearce, Nonsense-mediated decay in genetic disease: friend or foe? Mutat. Res. /Rev. Mutat. Res. 762 (2014) 52-64, https://doi.org/10.1016/j.mrrev.2014.05.001.
[85]

S. Nasif, Inhibition of nonsense-mediated mrna decay reduces the tumorigenicity of human fibrosarcoma cells, Nar. Cancer 5 (3) (2023), https://doi.org/10.1093/narcan/zcad048.
[86]

C. Shoemaker, R. Green, Translation drives mrna quality control, Nat. Struct. Mol. Biol. 19 (6) (2012) 594-601, https://doi.org/10.1038/nsmb.2301.
[87]

J. Weischenfeldt, J. Waage, G. Tian, J. Zhao, I. Damgaard, J. Jakobsen, B. Porse, Mammalian tissues defective in nonsense-mediated mrna decay display highly aberrant splicing patterns, Genome Biol. 13 (5) (2012) R35, https://doi.org/10.1186/gb-2012-13-5-r35.
[88]

A. Garzia, S. Jafarnejad, C. Meyer, C. Chapat, T. Gogakos, P. Morozov, N. Sonenberg, The e3 ubiquitin ligase and rna-binding protein znf598 orchestrates ribosome quality control of premature polyadenylated mrnas, Nat. Commun. 8 (1) (2017), https://doi.org/10.1038/ncomms16056.
[89]

E. Sundaramoorthy, M. Leonard, R. Mak, J. Liao, A. Fulzele, E. Bennett, Znf598 and rack1 regulate mammalian ribosome-associated quality control function by mediating regulatory 40s ribosomal ubiquitylation, Mol. Cell 65 (4) (2017) 751-760.e4, https://doi.org/10.1016/j.molcel.2016.12.026.
[90]

I. Morozov, M. Jones, P. Gould, V. Crome, J. Wilson, A. Hall, M. Caddick, Mrna 3′ tagging is induced by nonsense-mediated decay and promotes ribosome dissociation, Mol. Cell. Biol. 32 (13) (2012) 2585-2595, https://doi.org/10.1128/mcb.00316-12.
[91]

S. Lee, G. Pratt, F. Martínez, G. Yeo, J. Lykke-Andersen, Target discrimination in nonsense-mediated mrna decay requires upf1 atpase activity, Mol. Cell 59 (3) (2015) 413-425, https://doi.org/10.1016/j.molcel.2015.06.036.
[92]

M.W.-L. Popp, L.E. Maquat, The dharma of nonsense-mediated mRNA decay in mammalian cells, Mol. Cells 37 (1) (2014) 1-8, https://doi.org/10.14348/molcells.2014.2193.
[93]

F. Fiorini, D. Bagchi, H. Hir, V. Croquette, Human upf1 is a highly processive rna helicase and translocase with rnp remodelling activities, Nat. Commun. 6 (1) (2015), https://doi.org/10.1038/ncomms8581.
[94]

Y. Kim, L. Maquat, Upfront and center in rna decay: upf1 in nonsense-mediated mrna decay and beyond, Rna 25 (4) (2019) 407-422, https://doi.org/10.1261/rna.070136.118.
[95]

S. Fritz, S. Ranganathan, C. Wang, J. Hogg,The rna-binding protein ptbp1 promotes atpase-dependent dissociation of the rna helicase upf1 to protect transcripts from nonsense-mediated mrna decay, J. Biol. Chem. 295 (33) (2020) 11613-11625, https://doi.org/10.1074/jbc.ra120.013824.
[96]

Z. Ge, B. Quek, K. Beemon, J. Hogg, Polypyrimidine tract binding protein 1 protects mrnas from recognition by the nonsense-mediated mrna decay pathway, Elife (2016) 5, https://doi.org/10.7554/elife.11155.
[97]

M. Änkö, M. Müller-McNicoll, H. Brandl, T. Curk, Č. Gorup, I. Henry, K. Neugebauer, The rna-binding landscapes of two sr proteins reveal unique functions and binding to diverse rna classes, Genome Biol. 13 (3) (2012) R17, https://doi.org/10.1186/gb-2012-13-3-r17.
[98]

J. Humphrey, W. Emmett, P. Fratta, A. Isaacs, V. Plagnol, Quantitative analysis of cryptic splicing associated with tdp-43 depletion, BMC Med. Genom. 10 (1) (2017), https://doi.org/10.1186/s12920-017-0274-1.
[99]

E. Tank, C. Figueroa‐Romero, L. Hinder, K. Bedi, H. Archbold, X. Li, S. Barmada, Abnormal rna stability in amyotrophic lateral sclerosis, Nat. Commun. 9 (1) (2018), https://doi.org/10.1038/s41467-018-05049-z.
[100]

Y. Harigaya, R. Parker, No‐go decay: a quality control mechanism for rna in translation, Wiley Interdiscip. Rev. - Rna 1 (1) (2010) 132-141, https://doi.org/10.1002/wrna.17.
[101]

C. Shoemaker, D. Eyler, R. Green, Dom34:hbs1 promotes subunit dissociation and peptidyl-trna drop-off to initiate no-go decay, Science 330 (6002) (2010) 369-372, https://doi.org/10.1126/science.1192430.
[102]

T. Tsuboi, K. Kuroha, K. Kudo, S. Makino, E. Inoue, I. Kashima, T. Inada, Dom34:hbs1 plays a general role in quality-control systems by dissociation of a stalled ribosome at the 3′ end of aberrant mrna, Mol. Cell 46 (4) (2012) 518-529, https://doi.org/10.1016/j.molcel.2012.03.013.
[103]

J. Lin, Y. Zhang, W. Frankel, Z. Ouyang, Pras: predicting functional targets of rna binding proteins based on clip-seq peaks, Plos Comput. Biol. 15 (8) (2019) e1007227, https://doi.org/10.1371/journal.pcbi.1007227.
[104]

N. Mukherjee, H. Wessels, S. Lebedeva, M. Sajek, M. Ghanbari, A. Garzia, U. Ohler, Deciphering human ribonucleoprotein regulatory networks, Nucleic Acids Res. 47 (2) (2018) 570-581, https://doi.org/10.1093/nar/gky1185.
[105]

Y. Yang, A. Crofts, N. Crofts, T. Okita, Multiple rna binding protein complexes interact with the rice prolamine rna cis-localization zipcode sequences, Plant Physiol. 164 (3) (2014) 1271-1282, https://doi.org/10.1104/pp.113.234187.
[106]

K. Nishiura, S. Kawashima, T. Nagai, Y. Oishi, N. Hosoda, H. Imataka, S. Hoshino, Dom 34 mediates targeting of exogenous rna in the antiviral oas/rnase l pathway, Nucleic Acids Res. 47 (1) (2018) 432-449, https://doi.org/10.1093/nar/gky1087.
[107]

M. Doma, R. Parker, Endonucleolytic cleavage of eukaryotic mrnas with stalls in translation elongation, Nature 440 (7083) (2006) 561-564, https://doi.org/10.1038/nature04530.
[108]

C. Kilchert, S. Wittmann, L. Vasiljeva, The regulation and functions of the nuclear rna exosome complex, Nat. Rev. Mol. Cell Biol. 17 (4) (2016) 227-239, https://doi.org/10.1038/nrm.2015.15.
[109]

K. Pan, Z. Huang, J. Lee, C. Wong, Current perspectives on the role of tramp in nuclear rna surveillance and quality control, Res. Rep. Biochem. 111 (2015), https://doi.org/10.2147/rrbc.s58509.
[110]

M. Fasken, A. Corbett, Process or perish: quality control in mrna biogenesis, Nat. Struct. Mol. Biol. 12 (6) (2005) 482-488, https://doi.org/10.1038/nsmb945.
[111]

O. Isken, L. Maquat, Quality control of eukaryotic mrna: safeguarding cells from abnormal mrna function, Genes Dev. 21 (15) (2007) 1833-3856, https://doi.org/10.1101/gad.1566807.
[112]

E. Aikio, Complementary analysis of proteome‐wide proteomics reveals changes in rna binding protein‐profiles during prostate cancer progression, Cancer Rep. 6 (10) (2023), https://doi.org/10.1002/cnr2.1886.
[113]

T. Stenum, A. Kumar, F. Sandbaumhüter, J. Kjellin, J. Jerlström-Hultqvist, P. Andrén, E. Holmqvist, Rna interactome capture in Escherichia coli globally identifies rna-binding proteins, Nucleic Acids Res. 51 (9) (2023) 4572-4587, https://doi.org/10.1093/nar/gkad216.
[114]

S. Panja, S. Woodson, Hexamer to monomer equilibrium of e. coli hfq in solution and its impact on rna annealing, J. Mol. Biol. 417 (5) (2012) 406-412, https://doi.org/10.1016/j.jmb.2012.02.009.
[115]

N. Srinivas, S. Rachakonda, R. Kumar, Telomeres and telomere length: a general overview, Cancers 12 (3) (2020) 558, https://doi.org/10.3390/cancers12030558.
[116]

A. Maicher, L. Kastner, M. Dees, B. Luke, Deregulated telomere transcription causes replication-dependent telomere shortening and promotes cellular senes-cence, Nucleic Acids Res. 40 (14) (2012) 6649-6659, https://doi.org/10.1093/nar/gks358.
[117]

L. Catto, Telomeric repeat-containing rna is dysregulated in acute myeloid leukemia, Blood Adv. 7 (22) (2023) 7067-7078, https://doi.org/10.1182/bloodadvances.2023010658.
[118]

S. Redon, I. Zemp, J. Lingner,A three-state model for the regulation of telomerase by TERRA and hnRNPA1, Nucleic Acids Res. 41 (19) (2013) 9117-9128, https://doi.org/10.1093/nar/gkt695.
[119]

E. Petti, V. Buemi, A. Zappone, O. Schillaci, P. Broccia, R. Dinami, S. Schoeftner, Sfpq and nono suppress rna:dna-hybrid-related telomere instability, Nat. Commun. 10 (1) (2019), https://doi.org/10.1038/s41467-019-08863-1.
[120]

H. Chu, C. Cifuentes-Rojas, B. Kesner, E. Aeby, H. Lee, C. Wei, J. Lee, Terra rna antagonizes atrx and protects telomeres, Cell 170 (1) (2017) 86-101.e16, https://doi.org/10.1016/j.cell.2017.06.017.
[121]

A. Bah, H. Wischnewski, V. Shchepachev, C. Azzalin, The telomeric transcriptome of schizosaccharomyces pombe, Nucleic Acids Res. 40 (7) (2011) 2995-3005, https://doi.org/10.1093/nar/gkr1153.
[122]

A. Grimes, S.B.C. Chandra, Significance of cellular senescence in aging and cancer, Cancer Res. Treat. 41 (4) (2009) 187, https://doi.org/10.4143/crt.2009.41.4.187.
[123]

S. Ghadaouia, M.A. Olivier, A. Martinez, N. Malaquin, G.B. Cardin, F. Rodier, Telomeric dysfunction triggers an unstable growth arrest leading to irreparable genomic lesions and entry into cellular senescence (2018), https://doi.org/10.1101/442533.
[124]

J.W. Lee, E.B.B. Ong, Genomic instability and cellular senescence: lessons from the budding yeast, Front. Cell Dev. Biol. 8 (2021) 619126, https://doi.org/10.3389/fcell.2020.619126.
[125]

J. Soudet, P. Jolivet, M.T. Teixeira, Elucidation of the DNA end-replication problem in Saccharomyces cerevisiae, Mol. Cell 53 (6) (2014) 954-964, https://doi.org/10.1016/j.molcel.2014.02.030.
[126]

H. Tanaka, M.-C. Yao, Palindromic gene amplification—An evolutionarily conserved role for DNA inverted repeats in the genome, Nat. Rev. Cancer 9 (3) (2009) 216-224, https://doi.org/10.1038/nrc2591.
[127]

B.A. Avin, C.B. Umbricht, M.A. Zeiger, Human telomerase reverse transcriptase regulation by DNA methylation, transcription factor binding and alternative splicing (Review), Int. J. Oncol. 49 (6) (2016) 2199-2205, https://doi.org/10.3892/ijo.2016.3743.
[128]

H. Kim, N. Kim, Y. Wang, E. Scarborough, J. Moore, Z. Diaz, J. Taylor, Mutations in prion-like domains in hnrnpa2b1 and hnrnpa1 cause multisystem proteinopathy and als, Nature 495 (7442) (2013) 467-473, https://doi.org/10.1038/nature11922.
[129]

M. Cao, B. Ryan, J. Wu, M. Curtis, R. Faull, M. Dragunow, E. Scotter,A panel of tdp-43-regulated splicing events verify loss of tdp-43 function in amyotrophic lateral sclerosis brain tissue (2023), https://doi.org/10.1101/2023.02.03.527079.
[130]

A. Prasad, V. Bharathi, V. Sivalingam, A. Girdhar, B. Patel, Molecular mechanisms of tdp-43 misfolding and pathology in amyotrophic lateral sclerosis, Front. Mol. Neurosci. 12 (2019), https://doi.org/10.3389/fnmol.2019.00025.
[131]

J. Higelin, M. Demestre, S. Putz, J. Delling, C. Jacob, A. Lutz, T. Boeckers, Fus mislocalization and vulnerability to dna damage in als patients derived hipscs and aging motoneurons, Front. Cell. Neurosci. 10 (2016), https://doi.org/10.3389/fncel.2016.00290.
[132]

Z. Sun, Z. Diaz, X. Fang, M. Hart, A. Chesi, J. Shorter, A. Gitler, Molecular determinants and genetic modifiers of aggregation and toxicity for the als disease protein fus/tls, Plos Biol. 9 (4) (2011) e1000614, https://doi.org/10.1371/journal.pbio.1000614.
[133]

V. Kumar, G. Hasan, M. Hassan, Unraveling the role of rna mediated toxicity of c9orf72 repeats in c9-ftd/als, Front. Neurosci. 11 (2017), https://doi.org/10.3389/fnins.2017.00711.
[134]

K. Mayl, Y. Lee, Disease mechanisms and therapeutic approaches in c9orf72 als-ftd, Biomedicines 9 (6) (2021) 601, https://doi.org/10.3390/biomedicines9060601.
[135]

K. Zhang, J. Daigle, K. Cunningham, A. Coyne, K. Ruan, J. Grima, T. Lloyd, Stress granule assembly disrupts nucleocytoplasmic transport, Cell 173 (4) (2018) 958-971.e17, https://doi.org/10.1016/j.cell.2018.03.025.
[136]

F. Gao, S. Almeida, R. López-González, Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder, Embo J. 36 (20) (2017) 2931-2950, https://doi.org/10.15252/embj.201797568.
[137]

A. Montuschi, B. Iazzolino, A. Calvo, C. Moglia, L. Lopiano, G. Restagno, A. Chiò, Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in italy, J. Neurol. Neurosurg. Psychiatry 86 (2) (2014) 168-173, https://doi.org/10.1136/jnnp-2013-307223.
[138]

K. Trageser, E. Yang, C. Smith, R. Iban-Arias, T. Oguchi, M. Sebastian-Valverde, G. Pasinetti, Inflammasome-mediated neuronal-microglial crosstalk: a ther-apeutic substrate for the familial c9orf72 variant of frontotemporal dementia/amyotrophic lateral sclerosis, Mol. Neurobiol. 60 (7) (2023) 4004-4016, https://doi.org/10.1007/s12035-023-03315-w.
[139]

M. Pribadi, Z. Yang, T. Kim, E. Swartz, A. Huang, J. Chen, G. Coppola, Crispr-cas 9 Target. deletion thec9orf72repeat Expans. Mutat. corrects Cell. phenotypes Patient-Deriv. ips Cells (2016), https://doi.org/10.1101/051193.
[140]

L. Dratch, J. Owczarzak, W. Mu, K. Cousins, L. Massimo, M. Grossman, L. Erby, The lived experience of reconstructing identity in response to genetic risk of frontotemporal degeneration and amyotrophic lateral sclerosis, J. Genet. Couns. 33 (3) (2023) 515-527, https://doi.org/10.1002/jgc4.1749.
[141]

R. Bruin, T. Rabelink, A. Zonneveld, E. Veer, Emerging roles for rna-binding proteins as effectors and regulators of cardiovascular disease, Eur. Heart J. (2017) ehw567, https://doi.org/10.1093/eurheartj/ehw567.
[142]

K. Masuda, Y. Kuwano, Diverse roles of rna‐binding proteins in cancer traits and their implications in gastrointestinal cancers, Wiley Interdiscip. Rev. - Rna 10 (3) (2018), https://doi.org/10.1002/wrna.1520.
[143]

Q. Guo, Y. Wu, X. Guo, L. Cao, F. Xu, H. Zhao, X. Wu, The rna-binding protein celf2 inhibits ovarian cancer progression by stabilizing fam198b, Mol. Ther. — Nucleic Acids 23 (2021) 169-184, https://doi.org/10.1016/j.omtn.2020.10.011.
[144]

J. Han, Ö. An, X. Ren, Y. Song, S. Tang, H. Shen, L. Chen, Multilayered control of splicing regulatory networks by dap3 leads to widespread alternative splicing changes in cancer, Nat. Commun. 13 (1) (2022), https://doi.org/10.1038/s41467-022-29400-7.
[145]

G. Hu, Q. Jiang, L. Liu, H. Peng, Y. Wang, S. Li, Z. Liu, Integrated analysis of rna-binding proteins associated with the prognosis and immunosuppression in squamous cell carcinoma of head and neck, Front. Genet. 11 (2021), https://doi.org/10.3389/fgene.2020.571403.
[146]

D. Lujan, J. Ochoa, R. Hartley, Cold‐inducible rna binding protein in cancer and inflammation, Wiley Interdiscip. Rev. - Rna 9 (2) (2018), https://doi.org/10.1002/wrna.1462.
[147]

C. He, F. Huang, K. Zhang, J. Wei, K. Hu, M. Liang, Establishment and validation of an rna binding protein-associated prognostic model for ovarian cancer, J. Ovarian Res. 14 (1) (2021), https://doi.org/10.1186/s13048-021-00777-1.
[148]

A. Ghidini, A. Cléry, F. Halloy, F. Allain, J. Hall, Rna‐protacs: degraders of rna‐binding proteins, Angew. Chem. 60 (6) (2020) 3163-3169, https://doi.org/10.1002/anie.202012330.
[149]

S. Chothani, S. Schäfer, E. Adami, S. Viswanathan, A.A. Widjaja, S.R. Langley, J. Tan, M. Wang, N.M. Quaife, C. Jian Pua, G. D'Agostino, S. Guna Shekeran, B. L. George, S. Lim, E. Yiqun Cao, S. van Heesch, F. Witte, L.E. Felkin, E.G. Christodoulou, J. Dong, S. Blachut, G. Patone, P.J.R. Barton, N. Hubner, S.A. Cook, O.J.L. Rackham, Widespread translational control of fibrosis in the human heart by RNA-binding proteins, Circulation 140 (11) (2019) 937-951, https://doi.org/10.1161/CIRCULATIONAHA.119.039596 Epub 2019 Jul 9. PMID: 31284728; PMCID: PMC6749977.
[150]

L. Qiao, L. Xu, Y. Liu, J. Wynn, R. Hernan, X. Zhou, C. Wk, Rare De. novo Var. 827 Congenit. diaphragmatic hernia probands implicate lonp 1 alyref N. Candidate risk Genes (2021), https://doi.org/10.1101/2021.06.01.21257928.
[151]

D. Shi, Rna-binding proteins in cardiomyopathies, J. Cardiovasc. Dev. Dis. 11 (3) (2024) 88, https://doi.org/10.3390/jcdd11030088.
[152]

M. D’Antonio, J. Nguyen, T. Arthur, H. Matsui, M. Donovan, A. D’Antonio‐Chronowska, K. Frazer, In heart failure reactivation of rna-binding proteins is associated with the expression of 1,523 fetal-specific isoforms, Plos Comput. Biol. 18 (2) (2022) e1009918, https://doi.org/10.1371/journal.pcbi.1009918.
[153]

J. Liu, X. Kong, M. Zhang, X. Yang, X. Xu, Rna binding protein 24 deletion disrupts global alternative splicing and causes dilated cardiomyopathy, Protein Cell 10 (6) (2018) 405-416, https://doi.org/10.1007/s13238-018-0578-8.
[154]

T. Zhang, L. Yu, J. Liu, Z. Zhang, W. Fu, L. Guo, X. Xiao-hong, Rbm 24 regulates alternative splicing switch in embryonic stem cell cardiac lineage differ-entiation, Stem Cells 34 (7) (2016) 1776-1789, https://doi.org/10.1002/stem.2366.
[155]

A. Kalsotra, K. Wang, P. Li, T. Cooper, Micrornas coordinate an alternative splicing network during mouse postnatal heart development, Genes Dev. 24 (7) (2010) 653-658, https://doi.org/10.1101/gad.1894310.
[156]

P. Ortiz-Sánchez, M. Villalba-Orero, M. López-Olañeta, J. Larrasa-Alonso, F. Sánchez-Cabo, C. Martí-Gómez, E. Lara‐Pezzi, Loss of srsf3 in cardiomyocytes leads to decapping of contraction-related mrnas and severe systolic dysfunction, Circ. Res. 125 (2) (2019) 170-183, https://doi.org/10.1161/circresaha.118.314515.
[157]

R. Si, J.T.O. Cabrera, A. Tsuji-Hosokawa, R. Guo, M. Watanabe, L. Gao, Y.S. Lee, J.S. Moon, B.T. Scott, J. Wang, A.W. Ashton, J.N. Rao, J.Y. Wang, J.X. Yuan, A. Makino, HuR/Cx 40 downregulation causes coronary microvascular dysfunction in type 2 diabetes, JCI Insight 6 (21) (2021) e147982,https://doi.org/10.1172/jci.insight.147982 PMID: 34747371; PMCID: PMC8663561.
[158]

Q. Shi, D.Y. Lee, D. Féliers, H.E. Abboud, M.A. Bhat, Y. Gorin, Interplay between RNA-binding protein HuR and Nox4 as a novel therapeutic target in diabetic kidney disease, Mol. Metab. 36 (2020) 100968,https://doi.org/10.1016/j.molmet.2020.02.011 Epub 2020 Feb 28. PMID: 32240965; PMCID: PMC7115155.
[159]

N. Jeffery, D. Chambers, B.M. Invergo, R.M. Ames, L.W. Harries, Changes to the identity of EndoC-βH1 beta cells may be mediated by stress-induced depletion of HNRNPD, Cell Biosci. 11 (1) (2021) 144,https://doi.org/10.1186/s13578-021-00658-6 PMID: 34301309; PMCID: PMC8305497.
[160]

V. Kumar, A. Kumar, M. Kumar, et al., NFκB (RelA) mediates transactivation of hnRNPD in oral cancer cells, Sci. Rep. 12 (2022) 5944, https://doi.org/10.1038/s41598-022-09963-7.
[161]

L. Qian, H. Shi, M. Ding, Comparative analysis of gene expression profiles in children with type 1 diabetes mellitus, Mol. Med. Rep. 19 (2019) 3989-4000, https://doi.org/10.3892/mmr.2019.10099.
[162]

K. Belanger, C.A. Nutter, J. Li, S. Tasnim, P. Liu, P. Yu, M.N. Kuyumcu-Martinez, CELF 1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart, Biochem. Biophys. Res. Commun. 503 (4) (2018) 3205-3211.
[163]

W. Qin, J.J. Shi, R.Y. Chen, et al., Curriculum vitae of CUG binding protein 1 (CELF1) in homeostasis and diseases: a systematic review, Cell Mol. Biol. Lett. 29 (2024) 32, https://doi.org/10.1186/s11658-024-00556-y.
[164]

C.A. Nutter, M.N. Kuyumcu-Martinez, Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications, Wiley Inter. Rev. RNA 9 (2) (2018), https://doi.org/10.1002/wrna.1459.
[165]

S.K. Verma, V. Deshmukh, P. Liu, C.A. Nutter, R. Espejo, M.L. Hung, M.N. Kuyumcu-Martinez, Reactivation of fetal splicing programs in diabetic hearts is mediated by protein kinase C signaling, J. Biol. Chem. 288 (49) (2013) 35372-35386.
[166]

T. Gu, E. Horová, A. Möllsten, N.A. Seman, H. Falhammar, M. Prázný, H.F. Gu, IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy, J. Diabetes Complicat. 26 (5) (2012) 393-398.
[167]

S. Sargazi, M.H. Nia, R. Saravani, M.J. Shahroudi, D. Jahantigh, M. Shakiba, IGF2BP 2 polymorphisms as genetic biomarkers for either schizophrenia or type 2 diabetes mellitus: a case-control study, Gene Rep. 20 (2020) 100680.
[168]

L.F. Zhang, Q. Pei, G.P. Yang, Y.C. Zhao, Y.F. Mu, Q. Huang, Y.L. Zhu, The effect of IGF2BP2 gene polymorphisms on pioglitazone response in Chinese type 2 diabetes patients, Pharmacology 94 (3-4) (2014) 115-122.
[169]

P. Rao, H. Wang, H. Fang, Q. Gao, J. Zhang, M. Song, Y. Zhou, Y. Wang, W. Wang, Association between IGF2BP2 polymorphisms and Type 2 diabetes mellitus: a case-control study and meta-analysis, Int J. Environ. Res Public Health 13 (6) (2016) 574,https://doi.org/10.3390/ijerph13060574 PMID: 27294943; PMCID: PMC4924031.
[170]

M. van Hoek, J.G. Langendonk, S.R. de Rooij, E.J. Sijbrands, T.J. Roseboom, Genetic variant in the IGF2BP2 gene may interact with fetal malnutrition to affect glucose metabolism, Diabetes 58 (6) (2009) 1440-1444.
[171]

J. Hong, M. Ami, S. Maurice S, M. Richard T, T. Charles A, Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons, Hum. Mol. Genet. 13 (24) (2004) 3079-3088.
[172]

S. Paul, W. Dansithong, S.P. Jog, I. Holt, S. Mittal, J.D. Brook, G.E. Morris, L. Comai, S. Reddy, Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex, J. Biol. Chem. 286 (44) (2011) 38427-38438, https://doi.org/10.1074/jbc.M111.255224Epub 2011 Sep 7. PMID: 21900255; PMCID: PMC3207417.
[173]

S. Hutten, D. Dormann, hnRNPA2/B1 function in neurodegeneration: it’sa gain, not a loss, Neuron 92 (4) (2016) 672-674.
[174]

J. Mattay, Current technical approaches to study RNA-Protein interactions in mRNAs and long non-coding RNAs, BioChem 3 (1) (2022) 1-14.
[175]

N.N. Salim, S.S. Ganaie, A. Roy, S. Jeeva, M.A. Mir, Targeting a novel RNA-protein interaction for therapeutic intervention of hantavirus disease, J. Biol. Chem. 291 (47) (2016) 24702-24714, https://doi.org/10.1074/jbc.M116.750729Epub 2016 Oct 12. PMID: 27733686; PMCID: PMC5114419.
[176]

A. Fradera-Sola, E. Nischwitz, M.E. Bayer, K. Luck, F. Butter, RNA-dependent interactome allows network-based assignment of RNA-binding protein function, Nucleic Acids Res 51 (10) (2023) 5162-5176, https://doi.org/10.1093/nar/gkad245PMID: 37070168; PMCID: PMC10250244.
[177]

Y. Li, D.J. McGrail, N. Latysheva, S. Yi, M.M. Babu, N. Sahni, Pathway perturbations in signaling networks: linking genotype to phenotype, Semin Cell Dev. Biol. 99 (2020) 3-11, https://doi.org/10.1016/j.semcdb.2018.05.001Epub 2018 May 10. PMID: 29738884; PMCID: PMC6230320.
[178]

D. Medina-Cleghorn, D.K. Nomura, Exploring metabolic pathways and regulation through functional chemoproteomic and metabolomic platforms, Chem. Biol. 21 (9) (2014) 1171-1184, https://doi.org/10.1016/j.chembiol.2014.07.007PMID: 25237861; PMCID: PMC4171689.
[179]

N.E. Farrawell, I.A. Lambert-Smith, S.T. Warraich, I.P. Blair, D.N. Saunders, D.M. Hatters, J.J. Yerbury, Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions, Sci. Rep. 5 (2015) 13416,https://doi.org/10.1038/srep13416 PMID: 26293199; PMCID: PMC4544019.
[180]

E. Pokrishevsky, L. Grad, N. Cashman, TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion, Sci. Rep. 6 (2016) 22155, https://doi.org/10.1038/srep22155.
[181]

Y. Wang, S.X. Chen, X. Rao, Y. Liu, Modulator-dependent RBPs changes alternative splicing outcomes in kidney cancer, Front. Genet. 11 (2020) 265.
[182]

D.S. Berger, A.N. Ladd, Repression of nuclear CELF activity can rescue CELF-regulated alternative splicing defects in skeletal muscle models of myotonic dystrophy, PLoS Curr. 4 (2012) RRN1305, https://doi.org/10.1371/currents.RRN1305PMID: 22453899; PMCID: PMC3286860.
[183]

A.N. Ladd, N. Charlet, T.A. Cooper, The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing, Mol. Cell Biol. 21 (4) (2001) 1285-1296, https://doi.org/10.1128/MCB.21.4.1285-1296.2001PMID: 11158314; PMCID: PMC99581.
[184]

S.E. Ahmadi, M. Soleymani, F. Shahriyary, M.R. Amirzargar, M. Ofoghi, M.D. Fattahi, M. Safa, Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy, Cancer Gene Ther. 30 (7) (2023) 936-954.
[185]

O. Rogoyski, A.P. Gerber, RNA-binding proteins modulate drug sensitivity of cancer cells, Emerg. Top. Life Sci. 5 (5) (2021) 681-685, https://doi.org/10.1042/ETLS20210193 PMID: 34328175; PMCID: PMC8726047.
[186]

A. Das, T. Sinha, S. Shyamal, A.C. Panda, Emerging role of circular RNA-protein interactions, Noncoding RNA 7 (3) (2021) 48,https://doi.org/10.3390/ncrna7030048 PMID: 34449657; PMCID: PMC8395946.
[187]

H.J. Hwang, Y.K. Kim, Molecular mechanisms of circular RNA translation, Exp. Mol. Med. (2024) 1-9.
[188]

Z. Wei-Yi, Z.R. Cai, J. Liu, W. De-Shen, H.Q. Ju, X. Rui-Hua, Circular RNA: metabolism, functions and interactions with proteins, Mol. Cancer 19 (2020) 1.
[189]

S. Hong, RNA binding protein as an emerging therapeutic target for cancer prevention and treatment, J. Cancer Prev. 22 (4) (2017) 203-210, https://doi.org/10.15430/JCP.2017.22.4.203 Epub 2017 Dec 30. PMID: 29302577; PMCID: PMC5751837.
[190]

B. Portz, B.L. Lee, J. Shorter, FUS and TDP-43 phases in health and disease, Trends Biochem Sci. 46 (2021) 550-563.
[191]

J.D. Laver, K. Ancevicius, P. Sollazzo, J.T. Westwood, S.S. Sidhu, H.D. Lipshitz, C.A. Smibert, Synthetic antibodies as tools to probe RNA-binding protein function, Mol. Biosyst. 8 (6) (2012) 1650-1657, https://doi.org/10.1039/c2mb00007eEpub 2012 Apr 5. PMID: 22481296.
[192]

P. Khan, J.A. Siddiqui, I. Lakshmanan, A.K. Ganti, R. Salgia, M. Jain, M.W. Nasser, RNA-based therapies: a cog in the wheel of lung cancer defense, Mol. Cancer 20 (2021) 1-24.
[193]

T.C. Roberts, R. Langer, M.J.A. Wood, Advances in oligonucleotide drug delivery, Nat. Rev. Drug Discov. 19 (2020) 673-694.
[194]

J.P. Bost, H. Barriga, M.N. Holme, A. Gallud, M. Maugeri, D. Gupta, S. El-Andaloussi, Delivery of oligonucleotide therapeutics: chemical modifications, lipid nanoparticles, and extracellular vesicles, ACS nano 15 (9) (2021) 13993-14021.
[195]

A.R. Julio, K.M. Backus, New approaches to target RNA binding proteins, Curr. Opin. Chem. Biol. 62 (2021) 13-23, https://doi.org/10.1016/j.cbpa.2020.12.006 Epub 2021 Jan 31. PMID: 33535093; PMCID: PMC8823266.
[196]

X. Lu, J. Zhong, L. Liu, W. Zhang, S. Zhao, L. Chen, F. Ge, The function and regulatory mechanism of RNA-binding proteins in breast cancer and their future clinical treatment prospects, Front. Oncol. 12 (2022) 929037.
[197]

Y. Xu, Y. Yuan, D.Q. Fu, Y. Fu, S. Zhou, W.T. Yang, Z. Tang, The aptamer-based RNA-PROTAC, Bioorg. Med. Chem. 86 (2023) 117299.
[198]

A.K. Jaiswal, M.L. Thaxton, G.M. Scherer, J.P. Sorrentino, N.K. Garg, D.S. Rao, Small molecule inhibition of RNA binding proteins in haematologic cancer, RNA Biol. 21 (1) (2024) 1-14, https://doi.org/10.1080/15476286.2024.2303558Epub 2024 Feb 8. PMID: 38329136; PMCID: PMC10857685.
[199]

K.I. Takayama, S. Matsuoka, S. Adachi, T. Honma, M. Yoshida, T. Doi, K. Shin-Ya, M. Yoshida, H. Osada, S. Inoue, Identification of small-molecule inhibitors against the interaction of RNA-binding protein PSF and its target RNA for cancer treatment, PNAS Nexus 2 (6) (2023) pgad203, https://doi.org/10.1093/pnasnexus/pgad203 PMID: 37388923; PMCID: PMC10304769.
[200]

M.S. Badar, S. Shamsi, J. Ahmed, M.A. Alam, Molecular Dynamics Simulations: Concept, Methods, and Applications, in:N. Rezaei (Ed.), Transdisciplinarity. Integrated Science, 5 Springer, Cham, 2022, https://doi.org/10.1007/978-3-030-94651-7_7.
[201]

S.A. Hollingsworth, R.O. Dror, Molecular dynamics simulation for all, Neuron 99 (6) (2018) 1129-1143, https://doi.org/10.1016/j.neuron.2018.08.011PMID: 30236283; PMCID: PMC6209097.
[202]

Z. Zhang, S. Balzarini, B. Parmar, K. Boonen, A. Vandeperre, K. Geuten, Rna Inter. capture brachypodium Reveals a Flower. Plant core rbpome (2020), https://doi.org/10.21203/rs.3.rs-23468/v1.
[203]

D. Essegian, T. Cunningham, C. Zerio, E. Chapman, J. Schatz, S. Schürer, Molecular dynamics simulations identify tractable lead-like phenyl-piperazine scaffolds as eif4a1 atp-competitive inhibitors, Acs Omega 6 (38) (2021) 24432-24443, https://doi.org/10.1021/acsomega.1c02805.
[204]

J. Kang, Q. Tang, J. He, L. Li, N. Yang, S. Yu, M. Wang, Y. Zhang, J. Lin, T. Cui, Y. Hu, P. Tan, J. Cheng, H. Zheng, D. Wang, X. Su, W. Chen, Y. Huang, RNAInter v4.0: RNA interactome repository with redefined confidence scoring system and improved accessibility, Nucleic Acids Res. 50 (D1) (2022) D326-D332, https://doi.org/10.1093/nar/gkab997.
[205]

J.I. Perez-Perri, B. Rogell, T. Schwarzl, et al., Discovery of RNA-binding proteins and characterization of their dynamic responses by enhanced RNA interactome capture, Nat. Commun. 9 (2018) 4408, https://doi.org/10.1038/s41467-018-06557-8.
[206]

S. Singh, S. Shyamal, A.C. Panda, Detecting RNA-RNA interactome, Wiley Inter. Rev. RNA 13 (5) (2022) e1715,https://doi.org/10.1002/wrna.1715 Epub 2022 Feb 8. PMID: 35132791.
[207]

K. Yazdani, D. Jordan, M. Yang, C. Fullenkamp, J. Schneekloth, D. Calabrese, R. Khan, Machine learning informs rna‐binding chemical space**, Angew. Chem. 135 (11) (2023), https://doi.org/10.1002/ange.202211358.
[208]

M. Eshaghi, O. Neustroeva, I. Chowdhury, P. Laitinen, M. Väänänen, N. Korvenlaita, T. Turunen, Construction of fusion protein for enhanced small rna loading to extracellular vesicles, Genes 14 (2) (2023) 261, https://doi.org/10.3390/genes14020261.
[209]

J. Yan, M. Zhu, A review about rna-protein-binding sites prediction based on deep learning, Ieee Access 8 (2020) 150929-150944, https://doi.org/10.1109/access.2020.3014996.
[210]

Y. Yagi, T. Teramoto, S. Kaieda, T. Imai, T. Sasaki, M. Yagi, T. Nakamura, Construction of a versatile, programmable rna-binding protein using designer ppr proteins and its application for splicing control in mammalian cells, Cells 11 (22) (2022) 3529, https://doi.org/10.3390/cells11223529.
[211]

X. Hu, Q. Zou, L. Yao, X. Yang, Survey of the binding preferences of rna-binding proteins to rna editing events, Genome Biol. 23 (1) (2022), https://doi.org/10.1186/s13059-022-02741-8.
[212]

N. DeSouza, Dysregulated expression patterns of circular rnas in cancer: uncovering molecular mechanisms and biomarker potential, Biomolecules 14 (4) (2024) 384, https://doi.org/10.3390/biom14040384.
[213]

S. Meyer, Optimization of a protein-targeted medicine into an rna-specific small molecule, Acs Chem. Biol. 18 (11) (2023) 2336-2342, https://doi.org/10.1021/acschembio.3c00476.
[214]

A. López‐Estévez, Personalized cancer nanomedicine: overcoming biological barriers for intracellular delivery of biopharmaceuticals, Adv. Mater. 36 (14) (2023), https://doi.org/10.1002/adma.202309355.
PDF (3297KB)

34

Accesses

0

Citation

Detail
Sections
Recommended

/

〈 〉